CCIT-DK is a national research center for experimental, translational, and clinical collaborations in the field of cancer immunology and cancer immunotherapy. The center is collaborating both locally, nationally, and internationally and has established itself as one of the leading centers for cancer immunotherapy in Europe. CCIT-DK has established the national network IMMUNONET and the Clinical-Academic Group in Cancer Immunotherapy (CAGci), in addition to numerous experimental and clinical studies.
CCIT-DK is located at Herlev Hospital and is managed by Professor and Consultant Inge Marie Svane, Professor Per Thor Straten and Professor Mads Hald Andersen.
Read more about the research center.
Follow CCIT-DK activites on Twitter.
National Center for Cancer Immune Therapy (CCIT-DK)
Organisation
Professor Inge Marie Svane is responsible for the clinical studies, specializing in malignant melanoma, and supervises Master's students, PhD students, and postdocs.
Professor Per thor Straten is responsible for several preclinical studies in tumor immunology and supervises both MSc and PhD students within his field.
Professor Mads Hald Andersen is responsible for preclinical and translational research projects characterising the natural immune response against malignant cells. He has founded several biotech companies, including IO Biotech ApS, and supervises Master's students, PhD students, and postdocs.
CCIT-DK has approximately 70 employees, including researchers, technical staff, and Master's students. The researchers and Master's students come from a number of different countries, both inside and outside of the European Union. CCIT-DK has a GMP certified laboratory for the preparation of therapeutic immunological cellular products for cell-based cancer immune therapy.